251 related articles for article (PubMed ID: 35806139)
1. Isolation and Characterization of Urinary Extracellular Vesicles from Healthy Donors and Patients with Castration-Resistant Prostate Cancer.
Lee H; Kang SJ; Lee J; Park KH; Rhee WJ
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806139
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular vesicles in castration-resistant prostate cancer.
Liao C; Huang Z; Liu J; Deng M; Wang L; Chen Y; Li J; Zhao J; Luo X; Zhu J; Wu Q; Fu W; Sun B; Zheng J
Crit Rev Oncol Hematol; 2024 May; 197():104348. PubMed ID: 38588967
[TBL] [Abstract][Full Text] [Related]
3. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
[TBL] [Abstract][Full Text] [Related]
4. Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
Joncas FH; Lucien F; Rouleau M; Morin F; Leong HS; Pouliot F; Fradet Y; Gilbert C; Toren P
Prostate; 2019 Nov; 79(15):1767-1776. PubMed ID: 31475741
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
[TBL] [Abstract][Full Text] [Related]
6. Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients.
Bhagirath D; Liston M; Akoto T; Lui B; Bensing BA; Sharma A; Saini S
Sci Rep; 2021 Apr; 11(1):8279. PubMed ID: 33859239
[TBL] [Abstract][Full Text] [Related]
7. Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer.
Woo HK; Park J; Ku JY; Lee CH; Sunkara V; Ha HK; Cho YK
Lab Chip; 2018 Dec; 19(1):87-97. PubMed ID: 30500003
[TBL] [Abstract][Full Text] [Related]
8. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
9. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
[TBL] [Abstract][Full Text] [Related]
10. MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.
Matsuzaki K; Fujita K; Tomiyama E; Hatano K; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Kato T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Uemura M; Tsujikawa K; Nonomura N
Transl Androl Urol; 2021 Apr; 10(4):1918-1927. PubMed ID: 33968679
[TBL] [Abstract][Full Text] [Related]
11. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
Med Oncol; 2024 Jun; 41(7):169. PubMed ID: 38839666
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.
Huang X; Yuan T; Liang M; Du M; Xia S; Dittmar R; Wang D; See W; Costello BA; Quevedo F; Tan W; Nandy D; Bevan GH; Longenbach S; Sun Z; Lu Y; Wang T; Thibodeau SN; Boardman L; Kohli M; Wang L
Eur Urol; 2015 Jan; 67(1):33-41. PubMed ID: 25129854
[TBL] [Abstract][Full Text] [Related]
13. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
16. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
[TBL] [Abstract][Full Text] [Related]
17. Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
Larson J; Ozen MO; Kohli M; Akin D; Demirci U
Adv Biol (Weinh); 2023 Jul; 7(7):e2200327. PubMed ID: 37300338
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
Chen TY; Mihalopoulos M; Zuluaga L; Rich J; Ganta T; Mehrazin R; Tsao CK; Tewari A; Gonzalez-Kozlova E; Badani K; Dogra N; Kyprianou N
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834162
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancer.
Choi WWY; Sánchez C; Li JJ; Dinarvand M; Adomat H; Ghaffari M; Khoja L; Vafaee F; Joshua AM; Chi KN; Guns EST; Hosseini-Beheshti E
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4701-4717. PubMed ID: 36222898
[TBL] [Abstract][Full Text] [Related]
20. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]